Landstedt-Hallin, Lena
11  results:
Search for persons X
?
1

Prognostic impact of type 1 and type 2 diabetes mellitus in..:

Karayiannides, Stelios ; Norhammar, Anna ; Landstedt-Hallin, Lena..
European Journal of Preventive Cardiology.  29 (2022)  13 - p. 1759-1769 , 2022
 
?
2

Clinical use of insulin degludec:

Vora, Jiten ; Cariou, Bertrand ; Evans, Marc...
Diabetes Research and Clinical Practice.  109 (2015)  1 - p. 19-31 , 2015
 
?
4

Postprandial C-peptide in type 2 diabetes:

Landstedt-Hallin, Lena ; Eggimann, Louise ; Hellström, Lena..
Diabetes Research and Clinical Practice.  50 (2000)  - p. 54-55 , 2000
 
?
5

Oral Glibenclamide Suppresses Glucagon Secretion during Ins..:

Landstedt-Hallin, Lena ; Adamson, Ulf ; Lins, Per-Eric
The Journal of Clinical Endocrinology & Metabolism.  84 (1999)  9 - p. 3140-3145 , 1999
 
?
7

Adding glimepiride to insulin+metformin in type 2 diabetes ..:

Nybäck-Nakell, Å. ; Adamson, U. ; Lins, P.E..
Diabetes Research and Clinical Practice.  103 (2014)  2 - p. 286-291 , 2014
 
?
9

Safety and efficacy of insulin detemir in clinical practice..:

Dornhorst, A. ; Lüddeke, H-J ; Sreenan, S....
International Journal of Clinical Practice.  61 (2007)  3 - p. 523-528 , 2007
 
?
11

Oral Glibenclamide Suppresses Glucagon Secretion during Ins..:

Landstedt-Hallin, L.
Journal of Clinical Endocrinology & Metabolism.  84 (1999)  9 - p. 3140-3145 , 1999
 
1-11